North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 - COVID-19 Impact and Regional Analysis By Organization Size (Small and Medium Organizations and Large Organizations), Offerings (Products, Platforms, and Services), Application (Product Design and Discovery, Product Development, Pre-Clinical Targeting, Assessment of Drugs and Other Biomedical Products, and Others), Clinical Indication (Cardiovascular Diseases, Neurodegenerative Diseases, Oncology, Rare Diseases, Metabolic Diseases, Immune Based Diseases, Infectious Diseases, and Others), and End User (Pharmaceutical and Biopharmaceutical Companies, Medical Technology Companies, Contract Research Organizations, and Others)

No. of Pages: 181    |    Report Code: TIPRE00029242    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1
  • 5.1.2 Rising need for faster drug approval
  • 5.1.3 Increased demand for cost-effective trials
  • 5.1.4 Advancements in simulation technologies
5.2 Market Opportunities
  • 5.2.1
  • 5.2.2 Expansion in personalized medicine research
  • 5.2.3 Growth in AI-driven predictive models
  • 5.2.4 Demand in complex disease modeling
5.3 Future Trends
  • 5.3.1
  • 5.3.2 Use of digital twins in drug testing
  • 5.3.3 Increased regulatory support for simulations
  • 5.3.4 Integration with patient-specific data
5.4 Impact of Drivers and Restraints

6. North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Regional Analysis

6.1 North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Overview
6.2 North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue 2019-2028 (US$ Million)
6.3 North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Forecast Analysis

7. North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Analysis – by Organization Size

7.1 Small and Medium Organizations and Large Organizations
  • 7.1.1 Overview
  • 7.1.2 Small and Medium Organizations and Large Organizations: North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2031 (US$ Million)

8. North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Analysis – by Offerings

8.1 Products
  • 8.1.1 Overview
  • 8.1.2 Products: North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Platforms
  • 8.2.1 Overview
  • 8.2.2 Platforms: North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)
8.3 Services
  • 8.3.1 Overview
  • 8.3.2 Services: North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)

9. North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Analysis – by Application

9.1 Product Design and Discovery
  • 9.1.1 Overview
  • 9.1.2 Services: North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Product Development
  • 9.2.1 Overview
  • 9.2.2 Services: North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Pre-Clinical Targeting
  • 9.3.1 Overview
  • 9.3.2 Services: North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Assessment of Drugs and Other Biomedical Products
  • 9.4.1 Overview
  • 9.4.2 Services: North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)

10. North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – North America Analysis

10.1 North America
  • 10.1.1 North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Breakdown, by Key Country, 2022 and 2028 (%)
  • 10.1.1.1 North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 US: North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.1.1 US: North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Breakdown, by Organization Size
    • 10.1.1.1.2 US: North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Breakdown, by Offerings
    • 10.1.1.1.3 US: North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Breakdown, by Application
  • 10.1.1.2 Canada: North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.2.1 Canada: North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Breakdown, by Organization Size
    • 10.1.1.2.2 Canada: North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Breakdown, by Offerings
    • 10.1.1.2.3 Canada: North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Breakdown, by Application
  • 10.1.1.3 Mexico : North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.3.1 Mexico : North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Breakdown, by Organization Size
    • 10.1.1.3.2 Mexico : North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Breakdown, by Offerings
    • 10.1.1.3.3 Mexico : North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Breakdown, by Application

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 InSilicoTrials Technologies
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Dassault Systèmes SE
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Certara Inc.
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Computational Life
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Ansys, Inc.
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Synopsys, Inc.
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Sensyne Health plc.
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Phesi
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 Tempus
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 Cerner Corporation
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market

  1. InSilicoTrials Technologies
  2. Dassault Systèmes SE
  3. Certara Inc.
  4. Computational Life
  5. Ansys, Inc.
  6. Synopsys, Inc.
  7. Sensyne Health plc.
  8. Phesi
  9. Tempus
  10. Cerner Corporation       
north-america-in-silico-trials-computational-modelling-and-simulation-for-medical-product-innovation-and-regulatory-clearance-market